Group One Trading’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Group One Trading’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,300	Closed	-$136K	–	5626
2015 Q2	$136K	Buy	3,300 +2,400	+267%	+$86K	﹤0.01%	2850
2015 Q1	$32K	Sell	900 -6,200	-87%	-$210K	﹤0.01%	3646
2014 Q4	$228K	Sell	7,100 -12,800	-64%	-$370K	﹤0.01%	2201
2014 Q3	$558K	Sell	19,900 -39,000	-66%	-$1.19M	0.01%	1537
2014 Q2	$1.78M	Buy	58,900 +38,000	+182%	+$1.05M	0.03%	780
2014 Q1	$579K	Sell	20,900 -32,500	-61%	-$850K	0.01%	1535
2013 Q4	$1.36M	Buy	53,400 +29,100	+120%	+$897K	0.02%	900
2013 Q3	$726K	Buy	24,300 +6,900	+40%	+$192K	0.01%	1274
2013 Q2	$500K	Buy	+17,400	New	+$479K	0.01%	1362

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Group One Trading's BRLI Position: Q1 2015 in Review

Group One Trading sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 1,959 shares — an estimated $66.3K sold.

Group One Trading first reported a position in BRLI in Q4 2013 and held it in 4 quarters. The position peaked at $903K in Q4 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

Group One Trading reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
Group One Trading sold 1,959 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $66.3K.
Group One Trading first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 4 quarters.
Group One Trading's BIO-REFERENCE LABS INC-NEW- position peaked at $903K in Q4 2013.
168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.